Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells

Blood

Volumn 91, Issue 4, 1998, Pages 1407-1417

  Sugimoto, Koichi ^a   Yamada, Konagi ^b   Egashira, Motoki ^b   Yazaki, Yoshio ^b   Hirai, Hisamaru ^b   Kikuchi, Akihiko ^b   Oshimi, Kazuo ^b  

^a JUNTENDO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DNA TOPOISOMERASE (ATP HYDROLYSING); EPITOPE; ETOPOSIDE; VINCRISTINE;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME LOCALIZATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS; MYELOID LEUKEMIA; PRIORITY JOURNAL;

EID: 0032519810     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.4.1407     Document Type: Article

References (47)

1. Wang JC: DNA topoisomerases. Annu Rev Biochem 65:635,1996
2. Watt PM, Hickson ID: Structure and function of type II DNA topoisomerases. Biochem J 303:681, 1994
3. Uemura T, Ohkura H, Adachi Y, Morino K, Shiozaki K, Yanagida M: DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell 50:917, 1987
4. Adachi Y, Luke M, Laemmli UK: Chromosome assembly in vitro: Topoisomerase II is required for condensation. Cell 64:137, 1991
5. Ishida R, Sato M, Narita T, Utsumi KR, Nishimoto T, Monta T, Nagata H, Andoh T: Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J Cell Biol 126:1341, 1994
6. Liu LF: DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351, 1989
7. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML: HRX involvement in de novo and secondary leukemias with diverse chromosome 1lq23 abnormalities. Blood 81:3197, 1993
8. Gill Super HJ, McCabe NR, Thirman M, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Preben P, Diaz M, Rowley JD: Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82:3705, 1993
9. Broeker PLS, Gill Super H, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S, Zeleznik-Le N, Rowley JD: Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87:1912, 1996
10. Apian PD, Chervinsky DS, Stanulla M, Burhans WC: Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87:2649, 1996
11. Jenkins JR, Ayton P, Jones T, Davies SL, Simmons DL, Harris AL, Sheer D, Hickson ID: Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localization of the gene to chromosome 3p24. Nucleic Acids Res 20:5587, 1992
12. Austin CA, Sng J-H, Patel S, Fisher M: Novel HeLa topoisomerase II is the lib isoform: Complete coding sequence and homology with other type II topoisomerases. Biochim Biophys Acta 1172:283, 1993
13. Negri C, Chiesa R, Cerino A, Bestagno M, Sala C, Zini N, Maraldi NM, Astaldi Ricotti GCB: Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170-and 180-kDa isozymes. Exp Cell Res 200:452, 1992
14. Petrov P, Drake FH, Loranger A, Huang W, Hancock R: Localization of DNA topoisomerase II in Chinese hamster fibroblasts by confocal and electron microscopy. Exp Cell Res 204:73, 1993
15. Zini N, Martelli AM, Sabatelli P, Santi S, Negri C, Astaldi Ricotti GCB, Maraldi NM: The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant. Exp Cell Res 200:460, 1992
16. Meyer KN, Kjeldsen E, Straub T, Knudsen BR, Hickson ID, Kikuchi A, Kreipe H, Boege F: Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J Cell Biol 136:775, 1997
17. Drake FH, Hofmann GA, Bartus HF, Mattern MR, Crooke ST, Mirabelli CK: Biochemical and pharmacological properties of p 170 and pl80 forms of topoisomerase II. Biochemistry 28:8154, 1989
18. Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH: Proliferation-and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ 2:209, 1991
19. Heck MMS, Hittelman WN, Earnshaw WC: Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 85:1086, 1988
20. Heck MMS, Earnshaw WC: Topoisomerase II: A specific marker for cell proliferation. J Cell Biol 103:2569, 1986
21. Kaufmann SH, McLaughlin SJ, Kastan MB, Liu LF, Karp JE, Burke PJ: Topoisomerase II levels during granulocytic maturation in vitro and in vivo. Cancer Res 51:3534, 1991
22. Nakajima T, Ohi N, Arai T, Nozaki N, Kikuchi A, Oda K: Adenovirus E1A-induced apoptosis elicits a steep decrease in the topoisomerase lia level during the latent phase. Oncogene 10:651,1995
23. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239, 1972
24. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251, 1980
25. Lazebnik YA, Cole S, Cooke CA, Nelson WG, Earnshaw WC: Nuclear events of apoptosis in vitro in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J Cell Biol 123:7, 1993
26. Kumar S: ICE-like proteases in apoptosis. Trends Biochem Sci 20:198, 1995
27. Martin SJ, Green DR: Protease activation during apoptosis: Death by a thousand cuts. Cell 82:349, 1995
28. Lazebnik YA, Kaufmann SH, Desmoyners S, Poirier GG, Earnshaw WC: Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346, 1994
29. Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC: Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 92:9042, 1995
30. Song Q, Lees-Miller SP, Kumar S, Zhang N, Chan DW, Smith GCM, Jackson SP, Alnemri ES, Litwack G, Khanna KK, Lavin MF: DNA-dependent protein kinase catalytic subunit: A target for an ICE-like protease in apoptosis. EMBO J 15:3238, 1996
31. Kaufmann SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res 49:5870, 1989
32. Casiano CA, Martin SJ, Green DR, Tan EM: Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 184:765, 1996
33. Kimura K, Nozaki N, Saijo M, Kikuchi A, Ui M, Enomoto T: Identification of the nature of modification that causes the shift of DNA topoisomerase IIβ to apparent higher molecular weight forms in the M phase. J Biol Chem 269:24523, 1994
34. Gorczyca W, Gong J, Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53:1945, 1993
35. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350, 1979
36. Chabner BA, Allegra CJ, Curt GA, Calabresi P: Antineoplastic agents, in Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Oilman AG: Goodman and Oilman's the Pharmacological Basis of Therapeutics (ed 9). New York, NY, McGraw-Hill, 1996, p 1233
37. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkicwicz Z: The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 53:3186, 1993
38. Jin P, Gu Y, Morgan DO: Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J Cell Biol 134:963, 1996
39. Sato F, Matsukawa Y, Matsumoto K, Nishino H, Sakai T: Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells. Biochem Biophys Res Commun 204:578, 1994
40. Aloni-Grinstein R, Schwartz D, Rotter V: Accumulation of wild-type p53 protein upon γ-irradiation induces a G2 arrest-dependent immunoglobulin K light chain gene expression. EMBO J 14:1392, 1995
41. Abboud CN, Liesveld JL: Granulopoiesis and monocytopoiesis, in Huffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology: Basic Principles and Practice (ed 2). New York, NY, Churchill Livingstone, 1995, p 255
42. Warrell RP, De Thé H, Wang Z-Y, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
43. Crenshaw DG, Hsieh T: Function of the hydrophilic carboxyl terminus of type II topoisomerase from Drosophila melanogastei: I: In vitro studies. J Biol Chem 268:21328, 1993
44. Dang Q, Alghisi GC, Gasser SM: Phosphorylation of the C-terminal domain of yeast topoisomerase II by casein kinase II affects DNA-protein interaction. J Mol Biol 243:10, 1994
45. Earnshaw WC, Halligan B, Cooke CA, Heck MMS, Liu LF: Topoisomerase II is a structural component of mitotic chromosome scaffolds. J Cell Biol 100:1706, 1985
46. Gasser SM, Laroche T, Falquet J, Boy de la Tour E, Laemmli UK: Metaphase chromosome structure: Involvement of topoisomerase II. J Mol Biol 188:613, 1986
47. Taagepera S, Rao PN, Drake FH, Gorbsky GJ: DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc Natl Acad Sci USA 90:8407, 1993